Track the Epigral Limited stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Chemicals sector, Epigral Limited has recorded 45 public disclosures. Market capitalisation: €47bn. The latest transaction was filed on 5 June 2023 (Purchase). Among the most active insiders: MAULIK JAYANTIBHAI PATEL. The full history is openly available.
45
Insider Decl.
n/a
Thresholds
€2m
45 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Epigral Limited Strong Buy (bullish), based on 2 analysts. Average price target: ₹1,728.00.
10Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,217 of 29,064 companies
65.9
score / 100
Value
62
Quality
70
FCF yld0.9%
Earn yld7.1%
EV/EBITDA9.5x
ROE16%
Gross mgn40%
Net mgn13%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.